Android Apple

Iovance Biotherapeutics, Inc. (IOVA): Short Seller Sentiment is Bearish on This Cancer Stock

By Yahoo! Finance   |   3 months ago
Iovance Biotherapeutics, Inc. (IOVA): Short Seller Sentiment is Bearish on This Cancer Stock

Insider Monkey compiled a list of the 10 worst cancer stocks according to short sellers, focusing on Iovance Biotherapeutics, Inc. Despite being heavily shorted, the company showed optimistic Q2 earnings, expects revenue growth, and plans to expand its clinical pipeline.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.